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the aim of this prospective cohort study was to investigate the association between intrauterine 
fetal growth patterns and periodontal status in pregnant women. fifty-three pregnant women 
were recruited. periodontitis was diagnosed based on probing pocket depth and clinical attachment 
level. Maternal urinary 8-hydroxy-2’-deoxyguanosine levels and body mass index were recorded. 
Ultrasonographic measurements of the biparietal diameter (BpD), abdominal circumference (Ac), 
and femur length (fL) were recorded, and estimated fetal weight (efW) was calculated. in addition, 
approximation spline curves of BPD, AC, FL, and EFW were obtained throughout the gestation period. 
Recorded delivery outcomes were gestational age (GA), birth weight and length, sex, placental weight, 
and umbilical cord length. Forty-four participants (34.1 ± 4.9 years) were analyzed. Mean neonatal 
birth weight was 2906.0 ± 544.4 g. On multiple regression analysis, birth weight was related with 
periodontitis (standardized β = −0.21, P = 0.001). For EFW and BPD, the curves of the periodontitis 
group were located lower than those of the non-periodontitis group, with significant differences after 
32 weeks and 20 weeks of GA, respectively. In conclusion, periodontal treatment before conception 
may be recommended and a good periodontal condition in the early stage of pregnancy at the latest is 
desirable for infant growth.
Low birth weight (LBW) neonates are at higher risk of postnatal mortality and morbidity and lifestyle diseases 
in adulthood1–4. In Japan, birth weight is decreasing each year, although more than 90% of neonates are born 
during the normal period of gestation (37–41 weeks). In 2016, the average birth weights were 3.05 kg for males 
and 2.96 kg for females, and 8.3% and 10.5%, respectively, were delivered with an LBW ( < 2500 g)5. Ethnicity/
race, low socioeconomic status, multiple pregnancy, smoking, alcohol, drug abuse, and microbial infection have 
been reported as risk factors for LBW6,7. Elucidation of the risk factors that affect fetal growth and birth weight 
is important.
Periodontal disease is thought to be one of the risk factors for LBW8–10. Local inflammation induced by peri-
odontal pathogens including lipopolysaccharide (LPS) plays important roles in the pathophysiological processes 
of LBW or other adverse outcomes10–14. Moreover, there are other possible mechanisms through the increase in 
oxidative stress related to periodontal tissue inflammation15,16. Oxidative stress, which results from a disturbance 
in the balance between the production of reactive oxygen species (ROS) and antioxidant defenses, is reported to 
be associated with LBW17,18. A meta-analysis based on the observational studies concluded that there was evi-
dence of an association between periodontal disease and LBW19.
Next, it would be useful to clarify whether periodontal treatment actually prevents LBW. However, some 
interventional studies reported that treatment of periodontal disease during pregnancy did not prevent adverse 
pregnancy outcomes20–23. A meta-analysis concluded that treatment of periodontal disease during pregnancy had 
no significant effect in reducing the incidence of LBW. The onset and duration of the periodontal therapy were 
generally unclear in the previous trials24. One of the possible reasons for the reported lack of effect of periodontal 
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treatment might be ineffective timing of the intervention. Thus, further studies are needed to determine the 
appropriate timing of periodontal treatment to avoid the negative effects of periodontal disease on fetal growth.
Most previous studies focused only on delivery outcomes to see any association between periodontal disease 
and fetal growth. However, cross-sectional studies based on birth weight could not sufficiently assess fetal/neo-
natal growth, because the delivery outcome data would be biased by possible growth restriction, such as preterm 
deliveries associated with maternal complications or iatrogenic preterm deliveries25. On the other hand, few stud-
ies reported the effect of periodontal disease on longitudinal patterns of intrauterine fetal growth throughout the 
entire gestational period.
Ultrasonography is the most frequently used tool for assessment of intrauterine fetal growth. Estimated fetal 
weight (EFW) is calculated using the biparietal diameter (BPD), femur length (FL), and abdominal circumference 
(AC) measured by ultrasonography. Fetal growth is diagnosed by comparing individual EFW with the stand-
ard EFW curve26,27. Ultrasonography could attempt to assess the pattern of increased fetal weight, the period 
when growth restriction happens, and the growth process of every part or organ of the fetal body selectively28,29. 
However, few studies have investigated the correlation between EFW and periodontal disease using ultrasonog-
raphy. We hypothesized that the effect of periodontal disease on fetal growth appears at a certain time. The aim 
of this prospective cohort study was to investigate the association between intrauterine fetal growth patterns and 
periodontal status in pregnant women.
Results
Figure 1 shows the flow chart for the present study participants. A total of 53 women agreed to participate in the 
study and underwent oral examinations. Nine participants who did not deliver in the hospital because of moving 
to another hospital (n = 5), intrauterine fetal death (n = 3), or who had multiple gestations (n = 1) were excluded. 
Finally, 44 participants (mean age 34.1 ± 4.9 years) were analyzed. Table 1 shows the characteristics of the partici-
pants. There were 13 women (29.5%) with baseline disease or pregnancy complications related to decreased birth 
weight. The details of maternal systemic conditions were as follows: (1) decreased birth weight: antiphospholipid 
syndrome, heart disease, mood syndrome, and pregnancy complications (threatened premature delivery, threat-
ened abortion, and pregnancy-induced hypertension); (2) no associations with BW: pregnancy with assisted 
reproductive technology, hypothyroidism, uterine myoma, and protein S deficiency; (3) increased birth weight: 
type 1 diabetes mellitus and attention deficit hyperactivity disorder. No women smoked or received periodontal 
Figure 1. Flow chart of the participants analyzed in the present study.
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treatment during pregnancy. The incidence of preterm birth (gestational age [GA] < 37 weeks) was 11.4% (n = 5). 
The mean birth weight of the neonates was 2906.0 ± 544.4 g. Four (9.1%) were LBW cases (<2500 g).
Table 2 shows the comparison between the non-periodontitis and periodontitis groups. The periodontitis 
group had lower birth weight than the non-periodontitis group (P = 0.016).
Birth length, GA at delivery, placental weight, umbilical cord length, and maternal systemic condition had 
positive correlations with birth weight (all P < 0.05). On the other hand, mean probing pocket depth (PPD) and 
clinical attachment level (CAL) were negatively correlated with birth weight (both P < 0.05). No significant asso-
ciation was observed between 8-hydroxy-2’-deoxyguanosine (8-OHdG) concentration and birth weight (Table 3), 
and between maternal parity and sex or birth weight (Table 4).
The results of multiple regression analysis are shown in Table 5. Birth weight was negatively correlated with 
periodontitis (standardized β = −0.21; P = 0.001) and positively correlated with GA at delivery (standardized 
β = 0.59; P < 0.001) and weight of the placenta (standardized β = 0.42; P < 0.001).
Figures 2–5 present the spline curves for EFW, BPD, FL, and AC. For EFW and BPD, the curves of the peri-
odontitis group were located lower than those of the non-periodontitis group throughout the entire gestational 
period. There were significant differences in EFW and BPD between the non-periodontitis group and the perio-
dontitis group at each week after 32 weeks and 20 weeks, respectively. FL and AC were not significantly different 
between the two groups in any week throughout the entire gestational period.
Discussion
The comparison of EFW curves between the non-periodontitis group and the periodontitis group showed that a 
significant difference in EFW began at 32 weeks of GA. The results suggest that the maternal periodontal condi-
tion in the first trimester was associated with fetal growth at a later GA. The previous longitudinal study reported 
that there was a significant difference in EFW between maternal obesity in the first trimester and normal maternal 
weight after 32 weeks of GA25. These timings were similar to the present study.
There was a significant difference in BPD at 20 weeks and later between the periodontitis and non-periodontitis 
groups, whereas there were no significant differences in FL and AC. EFW is calculated using BPD, FL, and AC 
measured by ultrasonography. Thus, the difference in BPD between the two groups may mainly contribute to that 
in EFW in the present study.
The median of birth weight at delivery was significantly higher in the non-periodontitis group than in the 
periodontitis group. This finding corresponds to the result of the EFW curve in the present study and is supported 
by the previous studies9,10. On the other hand, some clinical trials reported that maternal periodontal treatment 
did not prevent LBW20–23. Therefore, a systematic review did not recommend routine treatment of periodontal 
disease during pregnancy for decreasing the risk of LBW24. Based on the present results for the EFW and BPD 
curves, as well as the previous studies, periodontal intervention should be completed in the early stage of preg-
nancy at the latest, and maintaining a good periodontal condition afterwards is desirable.
Maternal age (y) 34.1 ± 4.9a
GA at oral examination (weeks) 14.3 ± 2.7
Urinary 8-OHdG (ng/mg CRE) 25.7 ± 13.0
Number of teeth present 28.7 ± 2.1
Mean PPD (mm) 2.4 ± 0.3
Mean CAL (mm) 2.4 ± 0.3
%BOP 19.8 ± 12.7
GA at delivery (weeks) 38.7 ± 2.6
Birth weight (g) 2906.0 ± 544.4
Birth length (cm) 49.6 ± 3.9
Time of delivery Premature delivery 5 (11.4)b
Classification of birth weight Low birth weight 4 (9.1)
Maternal parity Multiparous 10 (22.7)
Neonatal sex Male 18 (40.9)
Placental weight (g) 542.6 ± 101.1
Umbilical cord length (cm) 50.5 ± 9.7
PlI 0.6 ± 0.4
BMI (kg/m2) 20.5 ± 4.2
Maternal systemic condition Decreased BW 13 (29.5)
Nothing or no associations with BW 29 (65.9)
Increased BW 2 (4.5)
Periodontal condition Periodontitis 23 (52.3)
Table 1. Characteristics of participants. GA gestational age, 8-OHdG 8-hydroxy-2’-deoxyguanosine, PPD 
probing pocket depth, CAL clinical attachment level, %BOP percentage of bleeding on probing, PlI plaque 
index, BMI body mass index, BW birth weight. aMean ± standard deviation. bNumber (%).
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There were no significant associations between concentrations of 8-OHdG as a marker of oxidative stress and 
neonatal birth weight (r = 0.057, P = 0.715) or between concentrations of 8-OHdG and maternal periodontal 
condition (P = 0.069). Pregnancy itself can induce oxidative stress because of increasing metabolic activity in 
the placental mitochondria30. When oxidative stress levels are too high, it could interfere with normal placenta-
tion. The 8-OHdG levels in urine from pregnant women were associated with decreased birthweight, decreased 
head circumference, and increased risk of small-for-gestational-age fetus17,18,31–33. However, the present findings 
are inconsistent with these data. The possible reason for the inconsistency may depend on maternal age and 
8-OHdG levels. A previous study reported that the median urinary 8-OHdG level of healthy pregnant women 
Non-periodontitis Periodontitis
Pn = 21 n = 23
Maternal age (y) 34.5 ± 4.2a 33.8 ± 5.6 0.645d
GA at oral examination (weeks) 13.0 (12.0, 15.0)b 14.0 (12.0, 17.0) 0.379e
Urinary 8-OHdG (ng/mg CRE) 28.8 (16.9, 40.1) 18.9 (14.9, 24.4) 0.069
Mean PPD (mm) 2.2 ± 0.2 2.5 ± 0.3  < 0.001
Mean CAL (mm) 2.2 ± 0.2 2.6 ± 0.3  < 0.001
%BOP 14.4 (10.6, 27.7) 17.7 (12.0, 24.1) 0.511
GA at delivery (weeks) 39.0 (38.2, 40.0) 39.6 (37.3, 40.4) 0.724
Birth weight (g) 3122.0 (2856.0, 3431.0)
2818.0 (2546.0, 
3126.0) 0.016
Birth length (cm) 51.0 (49.8, 52.3) 50.0 (47.5, 52.0) 0.093
Time of delivery Premature delivery 1 (4.8)c 4 (17.4) 0.348f
Classification of birth weight Low birth weight 0 (0) 4 (17.4) 0.109
Maternal parity Multiparous 6 (28.6) 4 (17.4) 0.481
Neonatal sex Male 9 (42.9) 9 (39.1) 1.000
Placental weight (g) 568.8 ± 94.8 518.7 ± 102.8 0.101
Umbilical cord length (cm) 52.6 ± 9.0 48.6 ± 10.0 0.172
PlI 0.46 (0.25, 0.59) 0.67 (0.25, 0.96) 0.129
BMI (kg/m2) 19.7 ± 4.6 21.3 ± 3.7 0.210
Maternal systemic condition 0.267
Decreased BW 5 (23.8) 8 (34.8)
Nothing or no associations with BW 14 (66.7) 15 (65.2)
Increased BW 2 (9.5) 0 (0)
Table 2. Comparison between the non-periodontitis and periodontitis groups. GA gestational age, 8-OHdG 
8-hydroxy-2’-deoxyguanosine, PPD probing pocket depth, CAL clinical attachment level, %BOP percentage 
of bleeding on probing, PlI plaque index, BMI body mass index, BW birth weight. aMean ± standard deviation. 
bMedian (25 percentile, 75 percentile). cNumber (%). dNon-paired t-test. eMann-Whitney U test. fChi-squared 
test or Fisher’s exact test.
Birth weight
r P
Birth length (cm) 0.921  < 0.001a
Maternal age (y) 0.180 0.242
Urinary 8-OHdG (ng/mg CRE) 0.057 0.715
Mean PPD (mm) −0.409 0.006
Mean CAL (mm) −0.394 0.008
%BOP −0.160 0.300
GA at delivery (week) 0.834  < 0.001
Placental weight (g) 0.791  < 0.001
Umbilical cord length (cm) 0.373 0.013
PlI −0.149 0.334
BMI (kg/m2) −0.028 0.858
Maternal systemic condition 0.340 0.024b
Table 3. Correlations between birth weight and selected variables. 8-OHdG 8-hydroxy-2’-deoxyguanosine, 
PPD probing pocket depth, CAL clinical attachment level, %BOP percentage of bleeding on probing, GA 
gestational age, PlI plaque index, BMI body mass index. aPearson’s correlation analysis. bSpearman’s correlation 
analysis. Maternal systemic condition was analyzed using ordinal variables: decreased birth weight 1; nothing or 
no association with birth weight 2; and increased birth weight 3.
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(mean maternal age, 25 years) was 5.51 ng/mg CRE at 12 weeks of GA31. The 8-OHdG level is correlated with 
age34. In the present study, the mean maternal age was 34 years, and the mean 8-OHdG level was 25.7 ng/mg CRE 
(mean assay date, 14 weeks of GA). Therefore, it is conceivable that the relatively older age of the participants in 
the present study obscured the difference in 8-OHdG between the two groups.
There were some limitations of this study. First, all participants were recruited from Okayama University 
Hospital. This may limit the ability to extrapolate these findings to Japanese women in general. Furthermore, the 
participants might represent a specific subgroup; only two women were completely healthy. However, the women 
with systemic diseases received appropriate medical care. Multicenter studies are needed for external validity. 
Second, the periodontal condition could not be investigated in the second and third trimesters. Finally, previous 
studies confirmed that systemic inflammation and LPS can affect fetal growth11–13. However, these factors could 
not be investigated in the present study. Further studies are needed to explore the mechanism of the relationship 
between periodontitis and fetal growth.
Birth weight
Mean ± SD P
Maternal parity
Primiparous 2854.5 ± 594.8
0.252
Multiparous 3081.0 ± 273.7
Neonatal sex
Female 2810.2 ± 632.8
0.163
Male 3044.3 ± 355.9
Table 4. Comparison of birth weight by related variables. SD standard deviation. Non-paired t-test.
Independent variable
Non-standardized Standardized 
β P 95% CI R2B SE
Maternal age 2.75 6.365 0.02 0.669 −10.22–15.71 0.926
Urinary 8-OHdG −0.72 2.385 −0.02 0.764 −5.58–4.14
Multiparous (vs. primiparous) 57.03 66.426 0.04 0.397 −78.27–192.34
Female neonates (vs. male neonates) −122.07 66.226 −0.11 0.075 −256.96–12.83
GA at delivery 125.57 13.274 0.59 < 0.001 98.53–152.60
Placental weight 2.25 0.344 0.42 < 0.001 1.55–2.95
Umbilical cord length −5.34 3.316 −0.09 0.117 −12.10–1.41
BMI 3.77 6.727 0.03 0.579 −9.93–17.48
Periodontitis (vs. non-periodontitis) −228.16 59.232 −0.21 0.001 −384.81 – −107.51
%BOP −0.95 2.412 −0.02 0.697 −5.86–3.97
Maternal systemic condition 46.71 59.905 0.05 0.441 −75.31–168.73
Table 5. Multiple regression analysis of delivery outcomes. SE standard error, CI confidence interval, 8-OHdG 
8-hydroxy-2’-deoxyguanosine, GA gestational age, BMI body mass index, %BOP percentage of bleeding on 
probing. Maternal systemic condition was analyzed using ordinal variables: decreased birth weight 1; nothing or 
no association with birth weight 2; and increased birth weight 3.
Figure 2. Distribution of estimated fetal weight in the non-periodontitis and periodontitis groups. EFW 
estimated fetal weight, GA gestational week. Asterisks show a significant difference at each gestational week (t-
test, P < 0.05).
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In conclusion, after 20 weeks of gestation, BPD was significantly smaller in pregnant women with periodonti-
tis than in those without periodontitis. After 32 weeks of gestation, EFW was significantly smaller. These findings 
suggest that periodontal treatment before conception may be recommended and a good periodontal condition in 
the early stage of pregnancy at the latest is desirable for infant growth.
Methods
Study population. The present study was a longitudinal observational study. The sample size was calculated 
by G*Power. The effect size (f2) was set at 0.2, alpha error at 0.05, and power (1 – beta) at 0.8 for linear multiple 
regression (number of predictors was 10), and the minimum sample size was estimated to be 42 participants.
Figure 5. Distribution of abdominal circumference by group (non-periodontitis and periodontitis groups). AC 
abdominal circumference, GA gestational week.
Figure 3. Distribution of biparietal diameter by group (non-periodontitis and periodontitis groups). BPD 
biparietal diameter, GA gestational week. Asterisks show a significant difference at each gestational week (t-test, 
P < 0.05).
Figure 4. Distribution of femur length by group (non-periodontitis and periodontitis groups). FL femur length, 
GA gestational week.
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Pregnant women in the first and early second trimester were recruited between May 2014 and October 2016 
at the Department of Obstetrics and Gynecology, Okayama University Hospital. Included were those who agreed 
to participate in the present study and were planning to deliver at the hospital. Exclusion criteria were multiple 
pregnancy, intrauterine fetal death, and incomplete data on delivery outcome because of unexpected transfer to 
another hospital. Written, informed consent was obtained from each participant who agreed to participate. The 
protocol of the present study was approved by the Ethics Committee of Okayama University Graduate School of 
Medicine, Dentistry and Pharmaceutical Sciences (No. d11002). It was confirmed that all procedures were per-
formed in accordance with the relevant guidelines and regulations. The present study was performed in accord-
ance with the STROBE Statement.
Oral examination. Five trained dentists carried out the periodontal examination in the first or early sec-
ond trimester. PPD and CAL were assessed at six sites (mesio-buccal, mid-buccal, disto-buccal, mesio-lingual, 
mid-lingual, and disto-lingual) for all teeth present with a color-coded probe (Periodontal Probe #5, YDM Co., 
Tokyo, Japan). Bleeding on probing (BOP) was recorded as present or absent after probing. Mean PPD, mean 
CAL, and percentage of BOP-positive sites (%BOP) were calculated for each subject. The Plaque Index (PlI)35 was 
also obtained. For PPD and CAL, agreement ± 1 mm was 100% on preliminary calibration.
Participants were divided into two groups according to periodontal status, the non-periodontitis group 
and the periodontitis group. The presence of 4 or more teeth showing at least one site with PPD ≥ 4 mm and 
CAL ≥ 3 mm at the same site was diagnosed as periodontitis10,36.
Evaluation of oxidative stress. The urinary 8-OHdG level was measured to assess oxidative stress on the 
same day as the oral examination, because 8-OHdG has some advantages as a marker. 8-OHdG is present in the 
extracellular compartment following DNA damage caused by ROS, and it can be noninvasively obtained from 
urine, as well as serum. 8-OHdG is stable after sample collection, so that it has been used universally to assess 
oxidative stress37,38. The urinary 8-OHdG concentration was determined by an immunochromatographic assay 
using an automatic analyzer, the ICR-001 (Techno Medica Co., Ltd. Yokohama, Japan)39–41. The urine sample 
was diluted 2 times by distilled water, and 100 μl of the diluted sample were dropped on the testing card. After 
5 minutes, the adjusted 8-OHdG concentration was expressed as a ratio to the urinary creatinine concentration 
(ng/mg CRE).
Medical examination. Maternal height (cm) and weight (kg) were recorded at the first prenatal visit, as 
well as pre-pregnancy weight, and body mass index (BMI) was calculated (kg/m2). Information on maternal age, 
parity, baseline disease, complications during pregnancy, and medication use were obtained from the medical 
records. Maternal systemic conditions were decided based on the maternal baseline diseases and pregnancy com-
plications, and divided into 3 groups by the risk to fetal growth of these abnormalities: 1) decreased birth weight, 
2) no associations with BW, and 3) increased birth weight.
Ultrasonographic measurements of the BPD, AC, and FL were recorded by an obstetrician at each visit until 
delivery. They were blind to the results of the oral examinations. EFW was calculated according to the formula of 
the Japan Society of Ultrasound in Medicine26, which incorporates BPD, AC, and FL:
= . × + . × × .−EFW 1 07 BPD 3 00 10 AC FL3 1 2
Using the ultrasonographic measurements provided, the time-course regression curves for each participant 
were computed by a statistical software package. For modeling regression curves, exponential functions were 
adopted for BPD, FL, and AC, and a logistic curve was adopted for EFW. From the regression curves, the mean 
fetal measurements were obtained for each GA, and these measurements were splined. Estimated curves were 
created for the non-periodontitis group and the periodontitis group.
Delivery outcomes. At the time of delivery, GA, birth weight, birth length, sex, placental weight, and umbil-
ical cord length were recorded by a gynecologist or a nurse.
Statistical analysis. The distributions of this data were assessed by using Shapiro-Wilk test. After that, 
non-paired t-tests, Mann-Whitney U test, and chi-squared tests or Fisher’s exact tests were performed to com-
pare variables between the non-periodontitis and periodontitis groups. Correlations between birth weight and 
variables were analyzed by Pearson’s or Spearman’s correlation coefficients. Comparisons of birth weight were 
performed using non-paired t-tests in two sets of two groups divided by maternal parity (primipara/multipara) 
and neonatal sex (male/female), respectively.
Multiple regression analysis was performed to analyze the effects of the following independent variables on 
birth weight as a dependent variable: maternal age, 8-OHdG level, parity, neonatal sex, GA at delivery, placental 
weight, umbilical cord length, BMI, periodontal group (non-periodontitis/periodontitis), %BOP, and maternal 
systemic condition (decreased BW/nothing or no associations with BW/increased BW).
Estimated EFW, BPD, FL, and AC values were compared between the non-periodontitis and periodontitis 
groups at each GA using non-paired t-tests.
All data were analyzed and all estimated curves were created using SPSS version 22 (IBM Japan, Tokyo, Japan) 
with the level of significance set at P < 0.05.
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